我要投票 中国医大一院在男科医院行业中的票数:101
· 外 推 电 报 ·
2025-02-23 19:27:30 星期日

【中国医大一院是哪个国家的品牌?】

中国医大一院是什么牌子?「中国医大一院」是 中国医科大学附属第一医院 旗下著名品牌。该品牌发源于辽宁省沈阳市,在1907年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力中国医大一院品牌出海!通过在本页面挂载中国医大一院品牌的产品链接和联系邮箱,可以提高中国医大一院产品曝光!跨境电商爆单神器,目前只要100元/年哦~

中国医科大学附属第一医院,中国医大一院,始于1907年,专业从事提供医疗服务,集医疗改革、医院管理、经营于一体的企业。

中国医科大学附属第一医院是一所大型综合性三级甲等医院,也是一所具有光荣革命传统的医院。

新中国成立六十多年来,经过几代人艰苦卓绝的努力,医院不断发展壮大。1995年初,医院开创“以病人为中心”的服务理念,高举医院改革的旗帜,开城市大医院改革之先河,提出了一系列的创新与发展举措,其成果引起了国内外医疗界的瞩目。医院的改革经验被推向了全国,成为全国卫生战线的一面旗帜,对我国的医疗改革和医院管理产生了划时代的深远影响。

纵横百年,历经沧桑。进入21世纪后,中国医大一院进入了历史发展的新阶段,如今的中国医大一院已是人才济济,硕果累累,以人才实力和技术优势,发展成为国内外的区域性疑难急重症诊治中心,在国内外卫生界享有很高的声誉。医院在抗击非典、抗击手足口病、防治流感、抗震救灾等重大突发事件面中做出了突出贡献。

2014年初明确了医院的功能定位:以创建区域医疗中心为目标,以改革为动力,围绕发展高新技术,推动学科发展;加强医院信息化建设,使门诊流程更为规范,改善病人就医体验;积极践行公立大医院的社会责任,不断探索帮扶基层医院的新模式,为了切实提高基层医院的医疗水平,公司的帮扶工作坚持“输血与造血并重”的原则,加强对基层医疗机构和医生的培训,使受援医院的医疗技术水平和服务能力显著提升。

医院现有建筑面积33.5万平方米,编制床位2249张,现有职工4250人,其中有中国工程院院士1人,教育部长江学者特聘教授3人,副教授和教授级专家515人,有中华医学会专科分会主委(含名誉主委、前任主委、候任主委)8人,副主任委员5人。拥有包括PET-CT、高能电子直线加速器、640排CT、双源多层CT、3.0T核磁共振等设备。医院全年门急诊量约337万人次,出院近15万人次,手术服务量5万例,平均住院日8.45天。

医大一院浑南院区将于2017年年底正式开诊,编制床位2000张,配备医护及医辅人员3000名,是一所具有国际水平的公益性综合医院。一期建设将启动以肿瘤治疗中心为主的建设项目,后期建设包括干细胞移植中心、再生医学中心等较能代表国际诊疗水平的建设项目。医大一院浑南院区将与本部协同发展,在社会责任、疑难重症诊治、绿色发展、国际化服务、人文医院和互联便捷医疗等方面成为东北区域医疗服务机构的典范。


英文翻译:The First Affiliated Hospital of China Medical University, the First Affiliated Hospital of China Medical University, started in 1907, specializing in providing medical services and integrating medical reform, hospital management and operation. The First Affiliated Hospital of China Medical University is a large-scale comprehensive Grade-A hospital, and also a hospital with glorious revolutionary tradition. Since the founding of the people's Republic of China more than 60 years ago, through the hard work of several generations, the hospital has been growing. At the beginning of 1995, the hospital created the service concept of "patient-centered", held high the banner of hospital reform, started the reform of urban large hospitals, and put forward a series of innovation and development measures, the results of which attracted the attention of domestic and foreign medical circles. The experience of hospital reform has been pushed to the whole country and become a banner of the national health front, which has a profound and epoch-making impact on the medical reform and hospital management in China. It's been a hundred years. After entering the 21st century, the first hospital of China Medical University has entered a new stage of historical development. Now, the first hospital of China Medical University has become a regional diagnosis and treatment center for difficult and urgent cases at home and abroad, which enjoys a high reputation in the domestic and foreign health circles. The hospital has made outstanding contributions to the fight against SARS, hand, foot and mouth disease, influenza, earthquake relief and other major emergencies. At the beginning of 2014, the functional orientation of the hospital was made clear: to establish a regional medical center as the goal, reform as the driving force, around the development of high and new technology, to promote the development of disciplines; to strengthen the construction of hospital information, to make the outpatient process more standardized, to improve the patient's medical experience; to actively practice the social responsibility of the public hospital, to constantly explore a new model to help the grass-roots hospital, in order to effectively improve the foundation As for the medical level of the hospital, the company adheres to the principle of "paying equal attention to blood transfusion and hematopoiesis" and strengthens the training of basic medical institutions and doctors, so as to significantly improve the medical technology level and service ability of the assisted hospital. The hospital has a building area of 335000 square meters, 2249 beds, 4250 employees, including 1 academician of Chinese Academy of engineering, 3 distinguished professors of Yangtze River scholars of the Ministry of education, 515 associate professors and professor level experts, 8 chairmen (including honorary chairman, former chairman and designate chairman) and 5 vice chairmen of the specialized branch of Chinese Medical Association. It has PET-CT, high energy electron linac, 640 row CT, dual source multi-slice CT, 3.0T NMR and other equipment. The hospital's outpatient and emergency treatment volume is about 3.37 million person times, nearly 150000 person times of discharge, 50000 cases of operation service, and the average hospital stay is 8.45 days. Hunnan Hospital District of the first hospital of Medical University will officially open its clinic at the end of 2017, with 2000 beds and 3000 medical and auxiliary personnel. It is a public welfare general hospital with international level. The first phase of construction will start a construction project focusing on cancer treatment center, and the later phase of construction includes stem cell transplantation center, regenerative medicine center and other construction projects that can better represent the international diagnosis and treatment level. Hunnan District, the first hospital of Medical University, will develop in coordination with the Ministry, and become a model of medical service institutions in Northeast China in terms of social responsibility, diagnosis and treatment of difficult and serious cases, green development, international services, humanistic hospitals and convenient medical services.

本文链接: https://www.waitui.com/brand/f9ac4e071.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

天岳先进:2024年净利润1.8亿元 同比扭亏为盈

36氪获悉,天岳先进发布业绩快报,公司2024年实现营业收入17.68亿元,同比增长41.37%;实现归属于母公司所有者的净利润1.80亿元,同比扭亏为盈。主要原因是公司大尺寸、导电型产品产能产量持续提升,销售量增加,同时产品毛利率上升。

2小时前

小米集团卢伟冰:小米15 Ultra会是越级式的一代产品

36氪获悉,小米集团合伙人兼总裁、手机部总裁、小米品牌总经理卢伟冰发文称,小米手机未来5年高端化的目标之一,就是要在6000元+价格段实现规模化的突破,“Ultra是6K+突破的关键产品,而小米15 Ultra会是越级式的一代产品”。

2小时前

恒瑞医药:羟乙磺酸达尔西利片联合内分泌治疗乳腺癌III期临床试验达主要终点

36氪获悉,恒瑞医药公告称,公司自主研发的羟乙磺酸达尔西利片在激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性女性乳腺癌辅助治疗的III期临床试验中,首次期中分析主要终点达到统计学显著性。研究结果显示,达尔西利联合内分泌治疗可显著降低患者复发风险,提高患者无侵袭性疾病生存期(IDFS)。公司已向国家药品监督管理局药品审评中心递交上市前沟通交流申请。该药品是公司自主研发的化学药品1类新药,是一种口服、高效、选择性的小分子CDK4/6抑制剂。

2小时前

深圳:近期将发布人形机器人专项政策 在全市科技重大专项中安排人工智能和机器人专项

深圳市政府新闻办2月23日召开“打造最好科技创新生态和人才发展环境”主题新闻发布会。市人工智能产业办主任林毅在会上表示,深圳在人工智能和机器人领域基础雄厚、未来可期。下一步,我们将在政策、场景、创新、机器人四个方面持续发力。此外,近期我们还将发布人形机器人专项政策,通过“揭榜挂帅”等方式,对开放应用场景、突破关键技术、构建专用数据集、提升规模化制造和应用能力等予以精准支持。同时,还将在全市科技重大专项中安排人工智能和机器人专项,鼓励产、学、研、用组成创新联合体进行协同攻关。(财联社)

2小时前

一汽大众ID.系列部分车型官降至高5.5万元

一汽-大众宣布对旗下ID.系列部分车型进行降价,最高降幅达5.5万元。此次降价活动涉及ID.4 CROZZ和ID.6 CROZZ两款车型,无门槛一口价分别为13.99万元和19.59万元起,还可叠加官方置换补贴至高1万元、国家置换补贴至高2万元。(财联社)

2小时前

本页详细列出关于郑州颐和医院的品牌信息,含品牌所属公司介绍,郑州颐和医院所处行业的品牌地位及优势。
咨询